Listed

United States 12 Month Oil Fund, LP

USLNYSECIK 1405528FinancialsFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue−$1.7m, Q2 FY2026
Net income−$1.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m15.7Revenue, Q3 FY2023, three months to 2023-09-30$15.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-28, accession 0001410578-25-000243.Report this figure(9.7)Revenue, Q4 FY2023, three months to 2023-12-31−$9.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-28, accession 0001410578-25-000243.Report this figure8.4Revenue, Q1 FY2024, three months to 2024-03-31$8.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure1.0Revenue, Q2 FY2024, three months to 2024-06-30$1.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure(6.9)Revenue, Q3 FY2024, three months to 2024-09-30−$6.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure3.1Revenue, Q4 FY2024, three months to 2024-12-31$3.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure0.5Revenue, Q1 FY2025, three months to 2025-03-31$460.1k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure(3.9)Revenue, Q2 FY2025, three months to 2025-06-30−$3.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure0.5Revenue, Q3 FY2025, three months to 2025-09-30$496.9k. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure(2.4)Revenue, Q4 FY2025, three months to 2025-12-31−$2.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure17.0Revenue, Q1 FY2026, three months to 2026-03-31$17.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure(1.7)Revenue, Q2 FY2026, three months to 2026-06-30−$1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure
Net income$m15.5Net income, Q3 FY2023, three months to 2023-09-30$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001410578-25-000243.Report this figure(9.8)Net income, Q4 FY2023, three months to 2023-12-31−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001410578-25-000243.Report this figure8.3Net income, Q1 FY2024, three months to 2024-03-31$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure0.9Net income, Q2 FY2024, three months to 2024-06-30$881.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure(7.0)Net income, Q3 FY2024, three months to 2024-09-30−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure2.9Net income, Q4 FY2024, three months to 2024-12-31$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure0.3Net income, Q1 FY2025, three months to 2025-03-31$344.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure(4.0)Net income, Q2 FY2025, three months to 2025-06-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure0.4Net income, Q3 FY2025, three months to 2025-09-30$373.7k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure(2.5)Net income, Q4 FY2025, three months to 2025-12-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure16.9Net income, Q1 FY2026, three months to 2026-03-31$16.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure(1.9)Net income, Q2 FY2026, three months to 2026-06-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure

Balance sheet

Cash and equivalents$34.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m26.4Cash and equivalents, Q3 FY2023, at 2023-09-30$26.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001410578-24-001823.Report this figure23.5Cash and equivalents, FY2023, at 2023-12-31$23.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure38.4Cash and equivalents, Q1 FY2024, at 2024-03-31$38.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001410578-25-001167.Report this figure41.0Cash and equivalents, Q2 FY2024, at 2024-06-30$41.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001410578-25-001638.Report this figure36.9Cash and equivalents, Q3 FY2024, at 2024-09-30$36.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001104659-25-108398.Report this figure31.9Cash and equivalents, FY2024, at 2024-12-31$31.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure34.1Cash and equivalents, Q1 FY2025, at 2025-03-31$34.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure36.1Cash and equivalents, Q2 FY2025, at 2025-06-30$36.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure35.4Cash and equivalents, Q3 FY2025, at 2025-09-30$35.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001104659-25-108398.Report this figure31.8Cash and equivalents, FY2025, at 2025-12-31$31.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure53.4Cash and equivalents, Q1 FY2026, at 2026-03-31$53.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure34.8Cash and equivalents, Q2 FY2026, at 2026-06-30$34.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure
Total assets$m77.4Total assets, Q3 FY2023, at 2023-09-30$77.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001410578-23-002214.Report this figure67.2Total assets, FY2023, at 2023-12-31$67.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001410578-25-000243.Report this figure64.1Total assets, Q1 FY2024, at 2024-03-31$64.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001410578-24-000686.Report this figure65.0Total assets, Q2 FY2024, at 2024-06-30$65.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001410578-24-001231.Report this figure54.0Total assets, Q3 FY2024, at 2024-09-30$54.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001410578-24-001823.Report this figure49.6Total assets, FY2024, at 2024-12-31$49.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure47.9Total assets, Q1 FY2025, at 2025-03-31$47.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001410578-25-001167.Report this figure42.4Total assets, Q2 FY2025, at 2025-06-30$42.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001410578-25-001638.Report this figure41.0Total assets, Q3 FY2025, at 2025-09-30$41.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001104659-25-108398.Report this figure36.8Total assets, FY2025, at 2025-12-31$36.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure65.5Total assets, Q1 FY2026, at 2026-03-31$65.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure40.7Total assets, Q2 FY2026, at 2026-06-30$40.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure
Total liabilities$m1.3Total liabilities, Q3 FY2023, at 2023-09-30$1.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001410578-23-002214.Report this figure0.2Total liabilities, FY2023, at 2023-12-31$225.7k. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0001410578-25-000243.Report this figure0.1Total liabilities, Q1 FY2024, at 2024-03-31$146.6k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001410578-24-000686.Report this figure0.1Total liabilities, Q2 FY2024, at 2024-06-30$108.3k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001410578-24-001231.Report this figure0.2Total liabilities, Q3 FY2024, at 2024-09-30$170.3k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001410578-24-001823.Report this figure0.2Total liabilities, FY2024, at 2024-12-31$219.5k. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-27, accession 0001104659-26-021509.Report this figure0.2Total liabilities, Q1 FY2025, at 2025-03-31$172.5k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001410578-25-001167.Report this figure0.1Total liabilities, Q2 FY2025, at 2025-06-30$142.9k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001410578-25-001638.Report this figure0.2Total liabilities, Q3 FY2025, at 2025-09-30$164.6k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001104659-25-108398.Report this figure0.2Total liabilities, FY2025, at 2025-12-31$172.2k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure5.7Total liabilities, Q1 FY2026, at 2026-03-31$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure0.1Total liabilities, Q2 FY2026, at 2026-06-30$112.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001104659-26-092628.Report this figure

Cash flow

Operating cash flow$5.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k3,182Operating cash flow, Q3 FY2023, three months to 2023-09-30$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001410578-24-001823. Derived: 9-month figure less the 6-month figure.Report this figure(29.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$29.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001104659-26-021509. Derived: 12-month figure less the 9-month figure.Report this figure1,056Operating cash flow, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001410578-25-001167.Report this figure2,498Operating cash flow, Q2 FY2024, three months to 2024-06-30$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001410578-25-001638. Derived: 6-month figure less the 3-month figure.Report this figure376Operating cash flow, Q3 FY2024, three months to 2024-09-30$375.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001104659-25-108398. Derived: 9-month figure less the 6-month figure.Report this figure(360)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$359.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001104659-26-021509. Derived: 12-month figure less the 9-month figure.Report this figure211Operating cash flow, Q1 FY2025, three months to 2025-03-31$211.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure(1,943)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001104659-26-092628. Derived: 6-month figure less the 3-month figure.Report this figure(438)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$438.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001104659-25-108398. Derived: 9-month figure less the 6-month figure.Report this figure(1,023)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001104659-26-021509. Derived: 12-month figure less the 9-month figure.Report this figure7,401Operating cash flow, Q1 FY2026, three months to 2026-03-31$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001104659-26-057771.Report this figure5,718Operating cash flow, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001104659-26-092628. Derived: 6-month figure less the 3-month figure.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.